论文部分内容阅读
肝硬变患者的胰腺内分泌激素改变越来越受到重视,本文观察了肝硬化患者60例的血清胰岛素(IRI)、胰高血糖素(IRG)及其二者比值,分析了IRI/IRG与肝功能、血氨的关系,并探讨了IRI/IRG与肝硬化患者预后的关系。观察对象为1985～1987年底随机抽样肝硬化患者60例,对其进行晨起静脉血IRI、IRG放免测定(应用海军总医院生产的IRI、IRG放免药盒),并进行相应辅助检查,如肝功、血氨、肝脾CT及B超等检查。 结果:(1)IRI/IRG与肝功能的关系:60例患者,其中肝功能代偿8例,失代偿52例。在肝硬化患者中,不论肝功能是否代偿均存在
Pancreatic hormone changes in patients with cirrhosis more and more attention, this paper observed 60 patients with cirrhosis serum insulin (IRI), glucagon (IRG) and the ratio between the two, IRI / IRG and liver Function, blood ammonia, and explored the relationship between IRI / IRG and the prognosis of patients with cirrhosis. The observation group was randomized to 60 patients with cirrhosis at the end of 1985-1997. The morning intravenous blood IRI and IRG radioimmunoassay (using the IRI and IRG radiopharmaceutical kit manufactured by the Navy General Hospital) were performed and the corresponding auxiliary examination such as liver Work, blood ammonia, liver and spleen CT and B ultrasound examination. Results: (1) The relationship between IRI / IRG and liver function: 60 patients, of which 8 patients were compensated for liver function and 52 patients were decompensated. In patients with cirrhosis, regardless of liver function are compensated